PTX-062

N/A

Report date: 2023/05/06 11:13:38

Base Information

Drug NamePTX-062
Drug Alias NamePTX-062
ClassificationSmall molecules
Mechanisms of ActionChelating agents
TargetsNot applicable
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPleco Therapeutics BV
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A